Abstract The transcription factor p73 has been demonstrated to play a significant role in survival and differentiation of neuronal stem cells. In this report, by employing comprehensive metabolic profile and mitochondrial bioenergetics analysis, we have explored the metabolic alterations in cortical neurons isolated from p73 N-terminal isoform specific knockout animals. We found that loss of the TAp73 or ΔNp73 triggers selective biochemical changes. In particular, p73 isoforms regulate sphingolipid and phospholipid biochemical pathway signaling. Indeed, sphinganine and sphingosine levels were reduced in p73-depleted cortical neurons, and decreased levels of several membrane phospholipids were also observed. Moreover, in line with the complexity associated with p73 functions, loss of the TAp73 seems to increase glycolysis, whereas on the contrary, loss of ΔNp73 isoform reduces glucose metabolism, indicating an isoform-specific differential effect on glycolysis. These changes in glycolytic flux were not reflected by parallel alterations of mitochondrial respiration, as only a slight increase of mitochondrial maximal respiration was observed in p73-depleted cortical neurons. Overall, our findings reinforce the key role of p73 in regulating cellular metabolism and point out that p73 exerts its functions in neuronal biology at least partially through the regulation of metabolic pathways.
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Introduction
The transcription factor p73 [1] [2] [3] , a member of the p53-family [4] [5] [6] [7] [8] , exerts its role through the regulation of several biological processes including cell survival [9] [10] [11] [12] [13] [14] , differentiation [15] [16] [17] [18] [19] , cellular metabolism [20] [21] [22] [23] [24] [25] , and autophagy [26] . This pleiotropic role of p73 is mainly due to the fact that the tp73 gene is expressed in numerous isoforms, including two main N-terminal isoforms: a full-length protein named TAp73, and a shorter, N-terminal truncated ΔNp73 isoform. It is generally accepted that the TA isoform is transcriptionally active while the ΔN isoform acts as dominant negative and therefore is transcriptionally inactive [1, 2, 8] . Notwithstanding these differences, mice generated by genetic deletion of the whole tp73 gene (p73−/−) [27] or selective N-terminal isoforms (TAp73−/− and ΔNp73−/−) [28, 29] all display postnatal alterations affecting the central nervous system (CNS). Indeed, the hippocampal dysgenesis observed in p73−/− and TAp73−/− mice manifests around 6 days of age, in agreement with the reported increase in TAp73 expression during neuronal maturation [30, 31] . On the other hand, the neuronal loss and reduced cognitive and motor functions affecting ΔNp73−/− mice start to be significantly evident in aged (26-27 months old) mice [29] . Overall, these findings indicate that p73 isoform is required for proper CNS development and neuronal homeostasis throughout the animal lifespan, although the downstream molecular pathways implicated appear complex and remain to be fully elucidated. Clearly, since p73 is a transcription factor, the phenotype observed in p73−/− mice is in part linked to regulation of gene expression. Indeed, several genes that are involved in neuronal biology, such as SOX-2 [32] , Hey-2 [33] , TRIM32 [34] , and p75NTR [35] , are either directly or indirectly regulated by TAp73 [36] [37] [38] [39] [40] . In addition, TAp73 controls the expression of miR-34a, suggesting that microRNAs [31, 41] also participate in the multifunctional role of p73 in neuronal developlment [31] . Growing findings indicate that p73 proteins also regulate cellular metabolism [42] [43] [44] [45] , and we have recently shown that during neuronal differentiation, TAp73 promotes the expression of glutaminase 2 (GLS2), an enzyme that deaminates glutamine to produce glutamate, the most common excitatory neurotransmitter [46] . This latter discovery nurtures the possibility that p73-mediated regulation of metabolism is an additional player in the regulation of neuronal function. In this report, performing global metabolic profiling on cortical neurons isolated from isoform specific knockout mice, we widened our previous observations and investigated TAp73 and ΔNp73 regulation of cellular metabolism in neuronal cells. We describe significant changes in few, but key, metabolites that point to ceramide signaling as potential targets regulated by both p73 isoforms. Moreover, consistent with the often intricate crosstalk between p73 isoforms, selective loss of the TAp73 and ΔNp73 leads to opposite outcomes on glycolysis and metabolism of neurotransmitters, but has a convergent effect on regulation of lipid signaling molecules.
Results
Global Metabolic Profile of Cortical Neurons Derived from TAp73−/− and ΔNp73−/− Mice p73 proteins play a key role in neuronal differentiation and survival [47] . Recently, we have also shown that p73 regulates cellular metabolism [20, 23, 42] . With regard to CNS, our previous data indicate that cortical neurons isolated from TAp73−/− mice appeared to have reduced levels of GABA, while levels of the inhibitory neurotransmitter glycine were reduced in ΔNp73−/− cells [46] . To investigate whether these changes belonged to a wider metabolic rewiring caused by loss of p73 expression, a global metabolic profile was carried out [48] in cortical neurons derived from TAp73−/− and ΔNp73−/− mice after 7 days of in vitro culture (DIV7). Eleven metabolites out of 217 were statistically (p < 0.05) different in cortical neurons of both genotypes when compared to wild-type (WT) control neurons (Tables 1 and 2 ). Moreover, we found that levels of 14 and 28 metabolites were nearly significantly (0.05 < p < 0.10) different in TAp73−/− and ΔNp73−/−, respectively, when compared to control cells. Overall, these findings suggest that p73 N-terminal isoforms regulate cellular metabolism in cortical neurons.
Bioenergetic Metabolism Is Potentially Affected by the Loss of p73
Glycolysis is the main energetic source for neurons and is essential neuronal cell survival [49] [50] [51] (Fig. 1a) . Although not statistically significant, several biochemicals relating to glucose utilization, including the glycolytic intermediates 2-phosphoglycerate and phosphoenolpyruvate and the end product lactate, were increased in TAp73−/− cortical neurons. These increments were accompanied by elevated intracellular glucose levels, suggesting that glucose uptake may be increased in these cells (Fig. 1b) , and overall identifying a potential inhibitory role for TAp73 in the regulation of glycolysis. Conversely, glucose and glycolytic intermediates were slightly reduced in ΔNp73−/− neurons. Within the cell, a second possible fate of glucose is fueling the pentose phosphate pathway (PPP), leading to biosynthesis of the 5-carbon sugar ribose 5-phosphate (Fig. 2a) . As shown in Fig. 2b , levels of ribose 5-phosphate were statistically reduced in cortical neurons derived from ΔNp73−/− mice, while in TAp73−/− counterparts, the reduction failed to reach the significance, ruling out a preferential channeling of glucose in the PPP pathway.
The changes observed in glucose metabolism, together with the compromised mitochondrial function caused by loss of TAp73 [23] , prompted us to investigate whether the loss of p73 could affect bioenergetics metabolism, on a wider scale. Toward this end, we took advantage of the Seahorse Extracellular Flux Analyzer, which allows measurement of the oxygen consumption rate (OCR), an indicator of mitochondrial activity, and performed a mitochondrial stress test in p73−/− cortical neurons (Fig. 3a) . We did not observe major alterations, although DIV7 cortical neurons derived from p73 −/− mice showed a slight, but significant, reduction in basal respiration when compared to cortical neurons derived from WT mice (Fig. 3b) . Moreover, the maximal respiratory capacity, measured following addition of the proton ionophore uncoupling agent FCCP, was higher in p73−/− cortical neurons (Fig. 3b) . Although statistically not significant, the same trend was also observed in cortical neurons derived from both N-terminal isoform specific knockout (Figs. S1 and S2). However, no differences between p73−/− and WT cortical neurons were observed in the expression levels of the several subunits of the ETC, namely ATP5A, UQCRC2, MTCO1, SDHB, and NDUF0B9, as assessed using Western blotting ( Fig. 3c and Fig. S3 ). Overall, these data indicates that p73 has a minimal effect on the regulation of mitochondrial activity in neuronal cells.
Fatty Acid Synthesis and Membrane Remodeling in the Absence of p73 Isoforms
We have recently reported that, during differentiation of wild-type (WT) cortical neurons, the levels of long chain fatty acids (LCFA) and lysolipids increase, whereas the intracellular content of medium chain fatty acids (MCFA) decreases [48] . This suggests that changes in lipid metabolism likely sustain the membrane remodeling that occurs during neuronal differentiation. Interestingly, our metabolic profile showed that in ΔNp73−/−, cortical neurons at DIV 7 LCFA were decreased as compared to WT cells (Fig. 4 and Table 2 ). In addition, as shown in Fig. 5b , membrane phospholipids, especially phosphocholine and phosphoethanolamine, were significantly reduced in ΔNp73−/− neurons. A trend toward reduced phospholipid levels was also observed in cortical neurons derived from TAp73−/−, although it failed to reach statistical significance (Fig. 5b) .
Overall, these results confirm previous findings showing that TAp73 is involved in the regulation of phospholipid biosynthesis [43] .
Sphingolipid Levels Are Reduced in p73 Deficient Cortical Neurons
The sphingolipid metabolic pathway produces the cellular membrane component sphingomyelin and the signaling molecule ceramide (Fig. 6a) , which is necessary for the proper differentiation of neuronal cells at least in part, acting as signaling molecule downstream of the p75NTR in hippocampal neurons [52, 53] . Moreover, sphinganine and sphingosine, the ceramide precursor and degradation products, respectively, are progressively elevated in differentiating cortical neurons, reflecting a sustained rate of sphingolipid metabolism. [48] . Notably, in the absence of either TAp73 or ΔNp73, these molecules were decreased, with a more dramatic effect in ΔNp73−/− cells (Fig. 6b) . Despite that our analysis failed to directly detect ceramide, the changes in its metabolites might suggest that altered sphingolipid metabolism could be partially responsible for the developmental defect and the aggravated neurodegeneration observed in the CNS of p73 deficient animals [54] [55] [56] .
Discussion
The p53 family, which is composed of the transcription factors p53 [57] [58] [59] , p63 [60, 61] , and p73, plays a key role in regulating cellular metabolism [62] [63] [64] . In particular, with a role in regulating gene expression, p73 has been demonstrated to play a significant role in neuronal cell biology, including 65] . To gain insight into the molecular mechanism by which p73 proteins regulate neuronal function, we carried out a global metabolic profiling in cortical neurons and show that the steady-state levels of several metabolites are altered following the loss of p73 Nterminal isoforms in DIV7 cortical neurons. Although the changes in metabolic profiles are subtle between genotypes, the data supports a role for p73 in regulating the differentiation of cortical neurons and points to GABA [46] and ceramide signaling as potential targets regulated by p73 isoforms.
Consistent with the complexity associated with p73 function, loss of the TAp73 and ΔNp73 isoforms has differential effects on glycolysis and neurotransmitter metabolism [46] but triggers similar effects on lipid signaling molecules.
Lipids are the most abundant compounds present in the brain [66] . More importantly, changes in lipid composition are associated with several neurological and psychiatric disorders [67] . In particular, alterations of myelin biogenesis have widely documented links to structural and functional abnormalities, including axonal and neuronal degeneration, ataxia, cortical neurons were harvested and levels of the indicated metabolites were assessed as described in BMaterial and Methods^section. Welch's two sample t tests were used to identify biochemicals that differed significantly between experimental groups (n = 5-6 for each group). To note the robust increase in intracellular levels of glucose in TAp73−/− mice and the opposite decrease in ΔNp73 −/− cells and tremor [68] . Interestingly, p73−/− mice show impairments in the peripheral nervous system with reduced thermal sensitivity, axon number, and myelin thickness [69] . Therefore, the decrease in sphinganine, sphingosine, and steraoyl sphingomyelin is found in TAp73−/− and ΔNp73−/−; cortical neurons may indicate that p73 isoforms regulate myelin biogenesis also in oligodendrocytes and Schwann cells. Even though this possibility should be experimentally tested, we would like to speculate that the reduction of myelin thickness observed in p73−/− mice could be in part explained by a reduction in the biosynthesis of myelin in oligodendrocytes and Schwann cells in absence of p73 isoforms. Interestingly, p73 appears to play a major role in regulating membrane physiology, as the described changes in sphingolipid metabolism were accompanied by alterations in membrane phospholipid, in keeping with our previous observation that TAp73 induces biosynthesis of membrane phospholipids in osteosarcoma cell line [43] . However, to determine whether these changes reflect persistent alterations of cellular metabolism, time course comparisons between WT and p73−/− neuronal cells at multiple time points to evaluate either global metabolism or selected metabolic pathways are warranted in future studies, supported by flux analysis of isotopic labeled compounds. In addition, it would be worth investigating the metabolic changes under pathological conditions, such as neurodegenerative disorders [70] [71] [72] . Overall, the findings presented in this report strengthen the recent experimental evidences that p73 isoforms play an essential role in regulating cellular metabolism and contribute to our understanding of the phenotypes observed in knock-out mice.
Materials and Methods

Mice
Mice were bred and subjected to listed procedures under the Project License PPL 40/3442 released from the Home Office. p73 full KO mice (p73−/−) were generated and genotyped as previously described [27] . TAp73−/− and ΔNp73−/− mice were generated and genotyped as previously described [28, 29] . Wild-type (WT), heterozygous (Het), and homozygous (−/−) mice for each genetic background were created by intercrossing Het mice. Offspring were genotyped by PCR analysis as previously described [22] [23] [24] . b DIV7 cortical neurons were harvested and levels of the indicated metabolites were assessed as described in BMaterial and Methods^section. Welch's two sample t tests were used to identify biochemicals that differed significantly between experimental groups (n = 5-6 for each group). Ribose-5-phopshate levels were significantly reduced in ΔNp73−/− cortical neurons
Cortical Neuron Preparation and Treatment
Primary cortical neurons were prepared from E17.5 embryos as previously described [48] . Briefly, cortices were harvested and cut into small pieces. Tissue was incubated with 1× Trypsin (Invitrogen, UK) for 10 min at 37°C. After washing with neurobasal medium (Invitrogen, UK) containing 10% FCS, penicillin (100 U), streptomycin (100 μ g) (Invitr ogen, UK), and 1× Glutamax (Invitrogen, UK), the tissue was resuspended by gentle pipetting. Cells were then counted using a hemocytometer, diluted to the appropriate concentration, and then plated in the aforementioned medium on poly-D-lysinecoated plates. After 1 h, the medium was replaced with growth medium (neurobasal medium (Invitrogen, UK) containing B27 supplement (Invitrogen, UK), penicillin (100 U), streptomycin (100 μg) (Invitrogen), and 1× Glutamax (Invitrogen, UK)) and maintained in culture for 7 days before being subjected to experimental procedures.
Global Metabolic Profiling
Cortical neurons were harvested at DIV7 and were immediately stored at −80°C. Samples were extracted and prepared for analysis using Metabolon's standard solvent extraction method (Metabolon, Inc. NC, USA). The sample preparation process was carried out as previously described [20] . Briefly, the protein fraction was removed by using a proprietary series of organic and aqueous extraction solutions. Then, the resulting extract was divided into two fractions: one for analysis by liquid chromatography (LC) and one for analysis by gas chromatography (GC). Each sample was first frozen and dried under vacuum. Samples were then processed for the appropriate instrument, either LC/MS or GC/MS. Instrument variability was determined by calculating the median relative standard deviation (RSD) for the internal standards that were added to each sample prior to injection into the mass spectrometers. Overall, process variability was determined by calculating the median RSD for all endogenous metabolites (i.e., non-instrument standards) present in 100% of the Client Matrix samples, which are technical replicates of pooled samples. Following normalization to total protein determined by Bradford assay, log transformation and imputation with minimum observed values were performed for each compound.
Extracellular Flux Analysis
Cortical neurons were seeded in XF 24-well cell culture microplate (Seahorse Bioscience, USA) in quintuplicate at 3 × 10 5 cells/well in 1 ml growth medium and then incubated at 37°C in 5% CO 2 . Assays were initiated, by removing the growth medium from each well and replacing it with fresh assay medium pre-warmed to 37°C. Oxygen consumption rate (OCR) was measured simultaneously for 3-5 min to establish a baseline rate. After the baseline measurement, 75-90 μl of a testing agent (Oligomycin, FCCP and Rotenone) was injected into each well to reach the desired final working concentration. Generally, two to three baseline rate and two or more response rate (after compound addition) measurements were taken, and the average of two baseline rate or response rate readings was used for data analysis. The values of OCR levels were normalized to protein content.
Western Blot
Proteins were extracted from DIV7 cortical neurons using RIPA buffer containing protease inhibitor cocktail (Roche, UK). Protein concentration was determined using a Bradford dye-based spectrophotometry assay (Biorad, UK). Total DIV7 cortical neurons were harvested and levels of the indicated fatty acids were measured in the described metabolomics profiling. Note the decreased levels of LCFA in ΔNp73−/− neurons. Welch's two sample t tests were used to identify biochemicals that differed significantly between experimental groups (n = 5-6 for each group). EFA essential fatty acid, MCFA medium chain fatty acid, LCFA long chain fatty acid protein was subjected to SDS-PAGE followed by immunoblotting with the indicated antibodies at the recommended dilutions. The following antibodies were used:
MitoProfile® Total OXPHOS Rodent WB Antibody Cocktail (mouse, 1:250, Abcam, UK), β-Tubulin (rabbit, 1:1000, Santa Cruz, UK). 
Statistical Analysis
All results are expressed as means ± standard deviation (SD). p < 0.05 was considered significant. In the metabolic profiling, Welch's two-sample t tests were used to identify biochemicals that differed significantly between experimental groups. Statistical analysis was performed using GraphPad Prism 6.
